Sumitomo Pharma Co., Ltd. GAAP EPS of ¥271.03, revenue of ¥347.7B
Source: SeekingAlpha
2026-02-02 08:09:23 ET
More on Sumitomo Pharma Co., Ltd.
- Seeking Alpha’s Quant Rating on Sumitomo Pharma Co., Ltd.
- Historical earnings data for Sumitomo Pharma Co., Ltd.
- Financial information for Sumitomo Pharma Co., Ltd.
Read the full article on Seeking Alpha
For further details see:
Sumitomo Pharma Co., Ltd. GAAP EPS of ¥271.03, revenue of ¥347.7B
Sumitomo Pharma Co. Ltd. ADR - 865614101
NASDAQ: SMDPY
SMDPY Trading
10.42% G/L:
$13.25 Last:
200 Volume:
$13.25 Open:
